Prestige Consumer Analyst Ratings

BenzingaFeb 13 11:54 ET

Oppenheimer Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Raises Target Price to $93

Moomoo NewsFeb 13 08:33 ET

D.A. Davidson Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Announces Target Price $104

Moomoo NewsFeb 10 08:31 ET

D.A. Davidson Sticks to Their Buy Rating for Prestige Consumer Healthcare (PBH)

TipRanksFeb 10 08:18 ET

Prestige Consumer Hlthcr Price Target Raised to $100.00/Share From $93.00 by Canaccord Genuity

Dow JonesFeb 7 14:10 ET

Prestige Consumer Hlthcr Is Maintained at Buy by DA Davidson

Dow JonesFeb 7 11:17 ET

Prestige Consumer Analyst Ratings

BenzingaFeb 7 11:08 ET

CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Raises Target Price to $100

Moomoo NewsFeb 6 17:32 ET

CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Maintains Target Price $93

Moomoo NewsJan 15 10:32 ET

Oppenheimer Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Raises Target Price to $87

Moomoo NewsJan 14 08:34 ET

CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Maintains Target Price $93

Moomoo NewsJan 7 07:34 ET

Sidoti Initiates Prestige Consumer Healthcare(PBH.US) With Hold Rating, Announces Target Price $90

Moomoo NewsDec 9, 2024 09:31 ET

Prestige Consumer Hlthcr Price Target Maintained With a $95.00/Share by DA Davidson

Dow JonesNov 11, 2024 11:48 ET

Prestige Consumer Analyst Ratings

BenzingaNov 11, 2024 11:38 ET

D.A. Davidson Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating

Moomoo NewsNov 11, 2024 08:31 ET

D.A. Davidson Sticks to Their Buy Rating for Prestige Consumer Healthcare (PBH)

TipRanksNov 11, 2024 08:08 ET

CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Raises Target Price to $93

Moomoo NewsNov 8, 2024 09:40 ET

CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Raises Target Price to $93

Moomoo NewsNov 8, 2024 08:38 ET

Prestige Consumer Hlthcr Price Target Raised to $76.00/Share From $70.00 by Jefferies

Dow JonesSep 24, 2024 09:13 ET

Prestige Consumer Analyst Ratings

BenzingaSep 24, 2024 09:03 ET